GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » Sloan Ratio %

Retractable Technologies (Retractable Technologies) Sloan Ratio %

: 0.55% (As of Dec. 2023)
View and export this data going back to 2001. Start your Free Trial

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Retractable Technologies's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.55%.

As of Dec. 2023, Retractable Technologies has a Sloan Ratio of 0.55%, indicating the company is in the safe zone and there is no funny business with accruals.


Retractable Technologies Sloan Ratio % Historical Data

The historical data trend for Retractable Technologies's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.91 23.39 41.84 9.97 0.55

Retractable Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.97 20.73 9.45 -5.93 0.55

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Retractable Technologies's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Retractable Technologies Sloan Ratio % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's Sloan Ratio % falls into.



Retractable Technologies Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Retractable Technologies's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-7.011-2.767
--10.762)/179.672
=0.55%

Retractable Technologies's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-7.011-2.766
--10.763)/179.672
=0.55%

Retractable Technologies's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 0.991 (Mar. 2023 ) + -3.869 (Jun. 2023 ) + -4.06 (Sep. 2023 ) + -0.073 (Dec. 2023 ) = $-7.01 Mil.
Retractable Technologies's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -3.7 (Mar. 2023 ) + -3.229 (Jun. 2023 ) + 7.801 (Sep. 2023 ) + 1.894 (Dec. 2023 ) = $2.77 Mil.
Retractable Technologies's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -9.602 (Mar. 2023 ) + -0.255 (Jun. 2023 ) + -0.558 (Sep. 2023 ) + -0.348 (Dec. 2023 ) = $-10.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Retractable Technologies  (AMEX:RVP) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Retractable Technologies has a Sloan Ratio of 0.55%, indicating the company is in the safe zone and there is no funny business with accruals.


Retractable Technologies Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Retractable Technologies (Retractable Technologies) Business Description

Traded in Other Exchanges
N/A
Address
511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.
Executives
Thomas J Shaw director, 10 percent owner, officer: President and CEO 511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard 10 percent owner 156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr director 816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley director 1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman director, officer: Vice President of Sales 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii director, officer: Chief Financial Officer 511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack director 1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut director 1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno 10 percent owner 777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August 10 percent owner 340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner director, officer: Exec. VP, Eng & Prod. 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza director P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu director 511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King director 9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios officer: Vice President/General Counsel 511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies (Retractable Technologies) Headlines